NCT06475989 2026-03-02Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid CancerEastern Cooperative Oncology GroupPhase 3 Recruiting264 enrolled
NCT02224781 2026-02-18Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 MelanomaNational Cancer Institute (NCI)Phase 3 Active not recruiting267 enrolled 8 charts